ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

Gianfranco Delle Fave(Azienda Ospedaliera Sant'Andrea), Dermot O’Toole(Trinity College Dublin), Anders Sundín(Uppsala University Hospital), Babs G. Taal(Cancer Genomics Centre), Piero Ferollà(University of Perugia), John Ramage(Hampshire Hospitals NHS Foundation Trust), Diego Ferone(University of Genoa), Tetsuhide Ito(Kyushu University Hospital), Wolfgang Weber(Memorial Sloan Kettering Cancer Center), Z. Zheng-Pei(Chinese Academy of Medical Sciences & Peking Union Medical College), Wouter W. de Herder(Erasmus MC), Andreas Pascher(Charité - Universitätsmedizin Berlin), Philippe Ruszniewski(Hôpital Beaujon), all other Vienna Consensus Conference participants
Neuroendocrinology
January 1, 2016
Cited by 488Open Access
Full Text

Abstract

New epidemiological data come from a study performed in Argentina These data are similar to the SEER data, where g-NENs were found to represent 8.7% of all enteric NENs [3] , and quite similar to a recent prospective Austrian study by Niederle et al. [4] , where g-NENs represented 5.6% of all digestive NENs. The proportions of g-NENs with respect to the overall NEN rates do vary, however; g-NENs represented 23% of all NENs in the Austrian study compared to 6% in the SEER data, 5% in a Canadian study (Ontario) and 7.4% in a Taiwanese study These differences underline the need for multicenter prospective studies with long-term analysis to better describe the European epidemiology of these tumors.


Related Papers

No related papers found

Powered by citation graph analysis